<- Go Home

Waters Corporation

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Market Cap

$19.1B

Volume

441.7K

Cash and Equivalents

$324.4M

EBITDA

$1.0B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$1.8B

Profit Margin

59.43%

52 Week High

$423.56

52 Week Low

$279.24

Dividend

N/A

Price / Book Value

10.43

Price / Earnings

29.98

Price / Tangible Book Value

-543.00

Enterprise Value

$20.5B

Enterprise Value / EBITDA

19.15

Operating Income

$837.5M

Return on Equity

42.82%

Return on Assets

11.40

Cash and Short Term Investments

$325.4M

Debt

$1.7B

Equity

$1.8B

Revenue

$3.0B

Unlevered FCF

$683.1M

Sector

Life Sciences Tools and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches